Faculty and junior investigators of the Michigan Alzheimer’s Disease Center are heading to the 2018 Alzheimer’s Association’s International Conference (AAIC) this weekend in Chicago, IL. AAIC is the world’s largest international conference focused on Alzheimer’s and dementia research. Our team has a large presence at the event with 23 faculty and junior investigators being represented in 8 presentations and 25 research posters. A complete list of our presence is available below.
Presentations
Dian-Tu Adaptive Prevention Trial Launch and Baseline Data
Sunday, July 22nd, 8:00 – 9:30AM at McCormick Place Room 183
Propagation and Diverse Effects of Disease-Specific Prion-like Tau Oligomeric Strains
Monday, July 23rd, 8:00 – 9:30AM at McCormick Place, Room 184
Task-Related fMRI Change after High-Definition Transcranial Direct Current Stimulation in Cognitively Intact Older Adults and Patients with MCI
Tuesday, July 24th, 8:00 – 9:30AM at McCormick Place Room 185
The Relationship between Tau PET and Other AD Biomarkers in Autosomal Dominant Alzheimer Disease
Tuesday, July 24th, 4:15 – 5:45PM at McCormick Place Room 196
A Biomarker-Based Nutritional Risk Index Explains the Heterogeneity in Rates of Cognitive Decline in the Multi-Domain Alzheimer Prevention Trial (MAPT)
Wednesday, July 25th, 8:00 – 9:30AM at McCormick Place Room 184
Psychosocial Outcomes of Apoe e4 Genotype Disclosure in the Generation Study
Wednesday, July 25th, 4:15 – 5:45PM at McCormick Place Room 179
US Race/Ethnic Minorities at High Cognitive Risk Use LESS Healthcare Resources
Thursday, July 26th, 11:45AM – 1:15PM at McCormick Place Room 184
The Lewy Body Dementia Association Research Centers of Excellence Program:Toward Optimizing Clinical Care and Clinical Trial Infrastructure
Thursday, July 26th, 8:30 – 10:00AM at McCormick Place Room 179
Contemporary Issues in Clinical Trials Methods
Friday, July 20th, 8:00AM – 5:00PM at Marriott Marquis Grand Horizon A
Posters
Comparing the Centiloid Scale for Pittsburgh Compound B and Florbetapir in Longitudinal PET Studies of Sporadic AD
Saturday, July 21st, 12:30 – 1:45PM at McCormick Place Hall F1
The Relationship between Tau PET and Other AD Biomarkers in Autosomal Dominant AD
Saturday, July 21st, 12:30 – 1:45PM at McCormick Place Hall F1
Memory System Functional Connectivity and Working Memory Performance in Subjective Memory Complaints
Saturday, July 21st, 12:30 – 1:45PM at McCormick Place Hall F1
Diffusion Modeling to Evaluate the Utility of Cogstate in Differentiating Normal Elderly, Mild Cognitive Impairment, and Probable Alzheimer’s Disease
Sunday, July 22nd, 9:30AM – 4:15PM at McCormick Place Hall F1
Behavioral Randomized Controlled Trial (RCT) Using Internet-Based Social Interactions As a Tool to Enhance Cognitive Reserve
Sunday, July 22nd, 9:30AM – 4:15PM at McCormick Place Hall F1
Declining Dementia Incidence in the Monongahela Valley: Birth Cohort Analyses from the Movies and Myhat Studies
Sunday, July 22nd, 9:30AM – 4:15PM at McCormick Place Hall F1
Noradrenergic Mechanisms of Vascular and Neuronal Pathophysiology in Preclinical Alzheimer’s Disease
Sunday, July 22nd, 9:30AM – 4:15PM at McCormick Place Hall F1
An Introduction and Overview to the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA)
Sunday, July 22nd, 9:30AM – 4:15PM at McCormick Place Hall F1
Impact of Patient Mild Cognitive Impairment on Physician Decision Making for Treatment
Sunday, July 22nd, 9:30AM – 4:15PM at McCormick Place Hall F1
Diagnostic Utility of NIH Toolbox Cognition Battery in Older Adults with Amnestic Mild Cognitive Impairment
Monday, July 23rd, 9:30AM – 4:15PM at McCormick Place Hall F1
Impact of Mild Cognitive Impairment on Patient and Care Partner Preferences for Cardiovascular Treatment
Monday, July 23rd, 9:30AM – 4:15PM at McCormick Place Hall F1
The Design, Evaluation and Reporting of Non-Pharmacological, Cognition-Oriented Treatments (COTs) for Older Adults: Results of an Experts Survey
Monday, July 23rd, 9:30AM – 4:15PM at McCormick Place Hall F1
Investigating the Role of Ubiquilin2 in Age-Related Neurodegeneration
Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1
Comparing the Centiloid Scale for Pittsburgh Compound B and Florbetapir in Longitudinal PET Studies of Sporadic AD
Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1
Cognitive Stimulation and Cognitive Function Among Middle-Aged and Older Hispanic/Latino Adults in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1
Cognition-Oriented Treatments Article Library and Evaluation (CogTale): A Novel Online Platform for Cognitive Intervention Research Evaluation, Synthesis, and Translation
Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1
The Alzheimer’s Prevention Initiative (API) Program: Design and Development of an Apoe Counseling and Disclosure Program
Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1
RNA Binding Dictates TDP43-Mediated Toxicity in Models of ALS and Ftd
Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1
The Oxytocin Receptor and Vascular Cognitive Impairment: Potential As a Novel Therapeutic Target
Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1
The Interaction between Tau and Protein Phosphatase 1 Is Affected By P301L Mutation
Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1
Tissue-Specific Genome-Wide Prediction of Genetically Regulated Gene Expression and Its Association with Neurocognitive Function in US Hispanics/Latinos
Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1
Ubiquilin-2 Regulation of Tau and α-Synuclein in Neurodegenerative Disease
Tuesday, July 24th, 9:30AM – 4:15PM at McCormick Place Hall F1
Pre-Statistical Harmonization of Cognitive Measures across Six Population-Based Cohorts: ARIC, Cardia, Chs, Fhs, MESA, and Nomas
Wednesday, July 25th, 9:30AM – 4:15PM at McCormick Place Hall F1
Strong Differentiation of Mild Cognitive Impairment and Alzheimer’s Disease Status Based on Functional Connectivity, Brain Graph Topology and Computer-Based Cognitive Assessment
Wednesday, July 25th, 9:30AM – 4:15PM at McCormick Place Hall F1
Following the conference, MADC Associate Director, Dr. Bruno Giordani will travel the state of Michigan to share the latest Alzheimer’s disease research with the public in a series of Research Nights from August 22nd – August 29th. These Research Nights are in partnership with the Alzheimer’s Association, Michigan Great Lakes chapter. More information regarding these events is available on our event calendar here.